Laurion Capital Management LP Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $20.4 Million - $28 Million	-74,400 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $6.26 Million - $7.29 Million	22,900 Added 44.47%	74,400 $20.6 Million
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $11 Million - $15.2 Million	36,600 Added 245.64%	51,500 $16.1 Million
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $3.68 Million - $4.35 Million	-9,900 Reduced 39.92%	14,900 $6.12 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $27 Million - $32.4 Million	-80,400 Reduced 76.43%	24,800 $9.26 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $28.6 Million - $33.3 Million	81,400 Added 342.02%	105,200 $42.5 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $10.3 Million - $12 Million	23,800	23,800 $10.6 Million

1,503

82.7M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.